These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23697940)

  • 41. (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes.
    Lawlor N; Stitzel ML
    Mol Metab; 2019 Sep; 27S(Suppl):S15-S24. PubMed ID: 31500827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetics in β-cell adaptation and type 2 diabetes.
    Kim H; Kulkarni RN
    Curr Opin Pharmacol; 2020 Dec; 55():125-131. PubMed ID: 33232934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Beta Cell in Type 2 Diabetes.
    Christensen AA; Gannon M
    Curr Diab Rep; 2019 Aug; 19(9):81. PubMed ID: 31399863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNAs and the functional β cell mass: For better or worse.
    Guay C; Regazzi R
    Diabetes Metab; 2015 Nov; 41(5):369-77. PubMed ID: 25910875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long noncoding RNAs in cardiac development and ageing.
    Devaux Y; Zangrando J; Schroen B; Creemers EE; Pedrazzini T; Chang CP; Dorn GW; Thum T; Heymans S;
    Nat Rev Cardiol; 2015 Jul; 12(7):415-25. PubMed ID: 25855606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural history of β-cell adaptation and failure in type 2 diabetes.
    Alejandro EU; Gregg B; Blandino-Rosano M; Cras-Méneur C; Bernal-Mizrachi E
    Mol Aspects Med; 2015 Apr; 42():19-41. PubMed ID: 25542976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of non-coding RNAs in pancreatic beta-cell development and physiology.
    Eliasson L; Esguerra JL
    Acta Physiol (Oxf); 2014 Jun; 211(2):273-84. PubMed ID: 24666639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of Galectin 3 in Pancreatic β Cells Amplifies β-Cell Apoptosis and Islet Inflammation in Type-2 Diabetes in Mice.
    Petrovic I; Pejnovic N; Ljujic B; Pavlovic S; Miletic Kovacevic M; Jeftic I; Djukic A; Draginic N; Andjic M; Arsenijevic N; Lukic ML; Jovicic N
    Front Endocrinol (Lausanne); 2020; 11():30. PubMed ID: 32117058
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of long non-coding RNAs in metabolic control.
    Ji E; Kim C; Kim W; Lee EK
    Biochim Biophys Acta Gene Regul Mech; 2020 Apr; 1863(4):194348. PubMed ID: 30594638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim.
    Nogueira TC; Paula FM; Villate O; Colli ML; Moura RF; Cunha DA; Marselli L; Marchetti P; Cnop M; Julier C; Eizirik DL
    PLoS Genet; 2013 May; 9(5):e1003532. PubMed ID: 23737756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent progress in studies of factors that elicit pancreatic β-cell expansion.
    Li Q; Lai ZC
    Protein Cell; 2015 Feb; 6(2):81-7. PubMed ID: 25492376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes.
    Khin PP; Lee JH; Jun HS
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets.
    Olsson AH; Volkov P; Bacos K; Dayeh T; Hall E; Nilsson EA; Ladenvall C; Rönn T; Ling C
    PLoS Genet; 2014 Nov; 10(11):e1004735. PubMed ID: 25375650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CXCL10- a path to β-cell death.
    Paroni F; Domsgen E; Maedler K
    Islets; 2009; 1(3):256-9. PubMed ID: 21099280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Roles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility.
    Pullen TJ; Rutter GA
    Front Genet; 2014; 5():193. PubMed ID: 25071823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. β-Cell failure in type 2 diabetes: a case of asking too much of too few?
    Costes S; Langen R; Gurlo T; Matveyenko AV; Butler PC
    Diabetes; 2013 Feb; 62(2):327-35. PubMed ID: 23349537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction.
    Guay C; Jacovetti C; Nesca V; Motterle A; Tugay K; Regazzi R
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():12-21. PubMed ID: 22928560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progenitor cells may aid successful islet compensation in metabolically healthy obese individuals.
    Singh H; Parthasarathy V; Farouk M; Venkatesan V
    Med Hypotheses; 2016 Jan; 86():97-9. PubMed ID: 26549352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micro RNA: an epigenetic regulator of type 2 diabetes.
    Kadamkode V; Banerjee G
    Microrna; 2014; 3(2):86-97. PubMed ID: 25412860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prenatal programming of insulin secretion in intrauterine growth restriction.
    Gatford KL; Simmons RA
    Clin Obstet Gynecol; 2013 Sep; 56(3):520-8. PubMed ID: 23820120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.